Two immunologists review evidence that bacterial vaginosis exhausts cervical T cells and that somatic hypermutation births new specificities.
HIV infects CD4 T cells using two co-receptors, CCR5 and CXCR4, so how much of those receptors a cell carries sets its susceptibility. Women with BV had higher frequencies of CCR5 and HLA positive cells, plus suppressed killer cells: more infectable targets and fewer cells able to kill infected ones.
Answered around 9:46Beyond CCR5, two markers were raised on their CD4 T cells: CD39 and CD101, both markers of metabolic stress, dysfunction, inhibition and exhaustion, in cervix and vaginal tissue. They also found fewer TCF1 positive CD4 T cells, a marker of stemness, so fewer progenitors left to differentiate.
Answered around 12:07Unlike the gut, where diversity is what counts as healthy, the vaginal canal wants close to a monoculture: majority lactobacillus, particularly crispatus, which thrives by producing chemicals that keep the pH very low. Polymicrobial states with Gardnerella or other lactobacillus such as iners are associated with dysbiosis and inflammation.
Answered around 4:13It is treatable by antibiotics, but of the women treated the recurrence rate is one in two, so 50 percent have reoccurring BV. Roughly one in four women get it at some point, and it is linked to increased STIs, preterm birth and preeclampsia. Trials add lactobacillus crispatus as a probiotic.
Answered around 6:47The Nugent score is the gold standard in clinical settings. It is based on the relative presence of three main bacterial types: lactobacillus, Gardnerella and Mobiluncus. Determining how much of each is present gives the score, and a higher Nugent score means BV while a lower score means you do not.
Answered around 5:11A cohort of 204 Kenyan women gave many sample types: vaginal tract samples, ectocervical biopsies, PBMCs, cervical vaginal fluid and serum. The team ran flow cytometry, immunofluorescent imaging and Luminex cytokine and chemokine profiling, comparing women with and without BV. The groups were at Fred Hutch, University of Washington and Nairobi.
Answered around 8:50The textbook definition is refinement of specificity: something that already binds is mutated so that it binds better, like putty fitting a groove even more closely. The enzyme behind it is activation-induced cytidine deaminase, which deaminates cytidines and changes the sequence at the antibody variable region.
Answered around 26:06They used mice whose B cells carry one clonal B cell receptor on a RAG knockout background, so no VDJ recombination: one antibody only, specific for influenza hemagglutinin and nothing else. Congenic markers and distinguishable antibody types let them track which cells and which antibodies came from that clonal population.
Answered around 31:54Mixed with B cell deficient muMT bone marrow, all the mice made detectable serum responses: OVA specific, PC specific and CGG specific. The HA antibodies had mutated and gained specificity for those antigens. Cloned monoclonals confirmed it, with the HA antibody binding ova in the nanomolar range.
Answered around 46:03In the first experiment there was almost no serum reactivity from the clonal cells, only germinal center B cells. Blocking the inhibitory signals on T cells produced some serum reactivity to PCC and a lot more to CGG, still none to ova, plus more germinal center B cells and more unique mutations.
Answered around 58:37“So the local immune dysregulation, it's not just systemic in blood.”
“I mean, they're just undergoing Darwinian evolution all the time in our body.”
“So really you can birth these new antibodies from an existing antibody that has completely different specificity.”
“And this would provide an opportunity to make specificities to practically anything.”
“Bacterial Vaginosis and T-Cell Dysfunction.” https://traffic.libsyn.com/secure/immune/Immune097.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/bacterial-vaginosis-and-t-cell-dysfunction.html.